Ignite Creation Date:
2024-05-06 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05254847
Status:
RECRUITING
Last Update Posted:
2022-04-04
First Post:
2022-02-15
Brief Title:
Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC
Sponsor:
Organization:
Fudan University